DOI QR코드

DOI QR Code

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients without Hereditary Hemorrhagic Telangiectasia

  • Shin, Ji-Hoon (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Park, Soo-Jin (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Ko, Gi-Young (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Yoon, Hyun-Ki (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Gwon, Dong-Il (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Kim, Jin-Hyoung (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Sung, Kyu-Bo (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center)
  • Received : 2009.05.26
  • Accepted : 2009.12.30
  • Published : 2010.06.01

Abstract

Objective: To evaluate the clinical and radiological outcomes of transcatheter embolotherapy for treating sporadic pulmonary arteriovenous malformations (PAVMs) that were not associated with hereditary hemorrhagic telangiectasia. Materials and Methods: Between January 2001 and June 2008, thirty-five sporadic PAVMs were detected in 23 patients. The clinical follow up consisted of assessing the changes of the signs and symptoms of the PAVMs, and radiological evaluation with chest radiographs or chest CT scans. Results: The lower lung regions (63%) and peripheral locations (86%) were the common locations of the PAVMs. Thirty-four PAVMs (97%) had simple architecture (one arterial feeder within a single pulmonary segment). Technical success was achieved in 33 PAVMs (94%); two cases of technical failure were due to catheterization failure (n = 1) and too large a feeding artery (17 mm) that disabled embolotherapy (n = 1). Coils and Amplatz vascular plugs were used in 30 and three PAVMs, respectively. Inadvertent placement of one coil (n = 1) and pulmonary infarction (n = 1) occurred, but no relevant symptoms developed. For the 13 patients with available data, the mean arterial $O_2$ saturation changed significantly from 92% to 98%. Complete or near-complete involution of the sac was observed in 30 of the 33 embolized PAVMs (91%). In these 33 embolized PAVMs, the mean sac diameter significantly decreased from 17.83 mm to 0.68 mm. Conclusion: Sporadic PAVMs are mostly the simple type with predominance in the lower lobe and peripheral locations. Transcatheter embolotherapy with coils or Amplatz vascular plugs is a safe and effective treatment for sporadic PAVMs and this provides excellent functional and radiological improvement.

Keywords

References

  1. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169:994-1000 https://doi.org/10.1164/rccm.200310-1441OC
  2. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996;7:787-804 https://doi.org/10.1016/S1051-0443(96)70851-5
  3. Cottin V, Chinet T, Lavole′A, Corre R, Marchand E, Reynaud- Gaubert M, et al. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007;86:1-17 https://doi.org/10.1097/MD.0b013e31802f8da1
  4. Gupta P, Mordin C, Curtis J, Hughes JM, Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR Am J Roentgenol 2002;179:347-355 https://doi.org/10.2214/ajr.179.2.1790347
  5. Mager JJ, Overtoom TT, Blauw H, Lammers JW, Westermann CJ. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004;15:451-456 https://doi.org/10.1097/01.RVI.0000126811.05229.B6
  6. Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI Jr. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006;17:35-44 https://doi.org/10.1097/01.RVI.0000191410.13974.B6
  7. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clinic Proc 1999;74:671-680 https://doi.org/10.4065/74.7.671
  8. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-67 https://doi.org/10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P
  9. Remy-Jardin M, Dumont P, Brillet PY, Dupuis P, Duhamel A, Remy J. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. Radiology 2006;239:576-585 https://doi.org/10.1148/radiol.2391050333
  10. Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI Jr. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest 2008;133:653-661 https://doi.org/10.1378/chest.07-1949
  11. White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988;169:663-669 https://doi.org/10.1148/radiology.169.3.3186989
  12. Dines DE, Arms RA, Bernatz PE, Gomes MR. Pulmonary arteriovenous fistulas. Mayo Clinic Proc 1974;49:460-465
  13. Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000;55:959-964 https://doi.org/10.1212/WNL.55.7.959
  14. Andersen PE, Kjeldsen AD. Occlusion of pulmonary arteriovenous malformations by use of vascular plug. Acta Radiol 2007;48:496-499 https://doi.org/10.1080/02841850701280866
  15. Ferro C, Rossi UG, Bovio G, Seitun S, Rossi GA. Percutaneous transcatheter embolization of a large pulmonary arteriovenous fistula with an amplatzer vascular plug. Cardiovasc Intervent Radiol 2007;30:328-331 https://doi.org/10.1007/s00270-005-0348-x
  16. Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. J Vasc Interv Radiol 2004;15:153-160 https://doi.org/10.1097/01.RVI.0000106390.63463.05
  17. Haitjema T, ten Berg JM, Overtoom TT, Ernst JM, Westermann CJ. Unusual complications after embolization of a pulmonary arteriovenous malformation. Chest 1996;109:1401-1404 https://doi.org/10.1378/chest.109.5.1401
  18. Brillet PY, Dumont P, Bouaziz N, Duhamel A, Laurent F, Remy J, et al. Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2-20-year follow-up. Radiology 2007;242:267-276 https://doi.org/10.1148/radiol.2421041571

Cited by

  1. Embolización de malformación arteriovenosa pulmonar con Amplatzer®. A propósito de un caso vol.108, pp.4, 2011, https://doi.org/10.1016/j.gmb.2011.08.003
  2. Clinical characteristics of pulmonary arteriovenous malformations in Koreans vol.20, pp.1, 2015, https://doi.org/10.1111/resp.12411
  3. Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation vol.9, pp.4, 2018, https://doi.org/10.22088/cjim.9.4.410
  4. Pulmonary arteriovenous shunt - a rare cause of recurrent stroke due to paradoxical embolism vol.120, pp.9, 2020, https://doi.org/10.17116/jnevro2020120091107
  5. Reperfusion of Pulmonary Arteriovenous Malformations Following Embolotherapy: A Randomized Controlled Trial of Detachable Versus Pushable Coils vol.43, pp.6, 2020, https://doi.org/10.1007/s00270-020-02422-8